Literature for peptidase A02.008: murine leukemia virus-type retropepsin

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2019
  1. Hakata,Y., Li,J., Fujino,T., Tanaka,Y., Shimizu,R. and Miyazawa,M.<br>Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing<br>PLoS Pathog (2019) 15, e1008173-e1008173. PubMed  Europe PubMed DOI
  2. 2012
  3. Furukawa,A., Okamura,H., Morishita,R., Matsunaga,S., Kobayashi,N., Ikegami,T., Kodaki,T., Takaori-Kondo,A., Ryo,A., Nagata,T. and Katahira,M.<br>NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavir<br>Biochem Biophys Res Commun (2012) 425, 284-289. PubMed  Europe PubMed DOI  I
  4. Loving,R., Wu,S.R., Sjoberg,M., Lindqvist,B. and Garoff,H.<br>Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering<br>Proc Natl Acad Sci U S A (2012) 109, 7735-7740. PubMed  Europe PubMed DOI  I
  5. Matsunaga,S., Sawasaki,T., Ode,H., Morishita,R., Furukawa,A., Sakuma,R., Sugiura,W., Sato,H., Katahira,M., Takaori-Kondo,A., Yamamoto,N. and Ryo,A.<br>Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis<br>J Proteomics (2012) 75, 4863-4873. PubMed  Europe PubMed DOI
  6. Matuz,K., Motyan,J., Li,M., Wlodawer,A. and Tozser,J.<br>Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin<br>FEBS J (2012) 279, 3276-3286. PubMed  Europe PubMed DOI  I
  7. Menendez-Arias,L., Tozser,J. and Oroszlan,S.<br>Moloney murine leukemia virus retropepsin<br>[ISSN:978-0-12-407744-7] (2012) 3, 226-230. DOI
  8. 2011
  9. Li,M., Dimaio,F., Zhou,D., Gustchina,A., Lubkowski,J., Dauter,Z., Baker,D. and Wlodawer,A.<br>Crystal structure of XMRV protease differs from the structures of other retropepsins<br>Nat Struct Mol Biol (2011) 18, 227-229. PubMed  Europe PubMed DOI  S
  10. Li,M., Gustchina,A., Matuz,K., Tozser,J., Namwong,S., Goldfarb,N.E., Dunn,B.M. and Wlodawer,A.<br>Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease<br>FEBS J (2011) 278, 4413-4424. PubMed  Europe PubMed DOI  S  I
  11. 2008
  12. Eizert,H., Bander,P., Bagossi,P., Sperka,T., Miklossy,G., Boross,P., Weber,I.T. and Tozser,J.<br>Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site<br>J Virol (2008) 82, 10111-10117. PubMed  Europe PubMed DOI  PMC  EPMC  P
  13. Vu,H.N., Ramsey,J.D. and Pack,D.W.<br>Engineering of a stable retroviral gene delivery vector by directed evolution<br>Mol Ther (2008) 16, 308-314. PubMed  Europe PubMed DOI
  14. 2006
  15. Feher,A., Boross,P., Sperka,T., Miklossy,G., Kadas,J., Bagossi,P., Oroszlan,S., Weber,I.T. and Tozser,J.<br>Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease<br>J Gen Virol (2006) 87, 1321-1330. PubMed  Europe PubMed DOI
  16. 2005
  17. Bagossi,P., Sperka,T., Feher,A., Kadas,J., Zahuczky,G., Miklossy,G., Boross,P. and Tozser,J.<br>Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites<br>J Virol (2005) 79, 4213-4218. PubMed  Europe PubMed DOI  PMC  EPMC  P
  18. 2004
  19. Feher,A., Boross,P., Sperka,T., Oroszlan,S. and Tozser,J.<br>Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli<br>Protein Expr Purif (2004) 35, 62-68. PubMed  Europe PubMed DOI  E
  20. Menendez-Arias,L., Tozser,J. and Oroszlan,S.<br>Moloney murine leukemia virus retropepsin<br>[ISSN:0-12-079610-4] (2004) 2, 176-178.  V
  21. Oshima,M., Muriaux,D., Mirro,J., Nagashima,K., Dryden,K., Yeager,M. and Rein,A.<br>Effects of blocking individual maturation cleavages in murine leukemia virus gag<br>J Virol (2004) 78, 1411-1420. PubMed  Europe PubMed DOI  PMC  EPMC
  22. 1999
  23. Boross,P., Bagossi,P., Copeland,T.D., Oroszlan,S., Louis,J.M. and Tozser,J.<br>Effect of substrate residues on the P2 ' preference of retroviral proteinases<br>Eur J Biochem (1999) 264, 921-929. PubMed  Europe PubMed DOI
  24. 1998
  25. Cannon,K., Qin,L., Schumann,G. and Boeke,J.D.<br>Moloney murine leukemia virus protease expressed in bacteria is enzymatically active<br>Arch Virol (1998) 143, 381-388. PubMed  Europe PubMed DOI
  26. 1996
  27. Tristem,M., Kabat,P., Lieberman,L., Linde,S., Karpas,A. and Hill,F.<br>Characterization of a novel murine leukemia virus-related subgroup within mammals<br>J Virol (1996) 70, 8241-8246. PubMed  Europe PubMed  PMC  EPMC
  28. 1995
  29. Menendez-Arias,L., Weber,I.T. and Oroszlan,S.<br>Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases<br>J Biol Chem (1995) 270, 29162-29168. PubMed  Europe PubMed DOI
  30. 1994
  31. Menendez-Arias,L., Weber,I.T., Soss,J., Harrison,R.W., Gotte,D. and Oroszlan,S.<br>Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease<br>J Biol Chem (1994) 269, 16795-16801. PubMed  Europe PubMed
  32. 1993
  33. Black,P.L., Downs,M.B., Lewis,M.G., Ussery,M.A., Dreyer,G.B., Petteway,S.R., Jr. and Lambert,D.M.<br>Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture<br>Antimicrobial Agents Chemother (1993) 37, 71-77. PubMed  Europe PubMed  PMC  EPMC
  34. Menendez-Arias,L., Gotte,D. and Oroszlan,S.<br>Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme<br>Virology (1993) 196, 557-563. PubMed  Europe PubMed DOI
  35. 1991
  36. Pettit,S.C., Simsic,J., Loeb,D.D., Everitt,L., Hutchison,C.A., III and Swanstrom,R.<br>Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid<br>J Biol Chem (1991) 266, 14539-14547. PubMed  Europe PubMed
  37. 1987
  38. [YEAR:15-10-1987]Katoh,I., Yasunaga,T., Ikawa,Y. and Yoshinaka,Y.<br>Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor<br>Nature (15-10-1987) 329, 654-656. PubMed  Europe PubMed DOI  I
  39. 1985
  40. Katoh,I., Yoshinaka,Y., Rein,A., Shibuya,M., Odaka,T. and Oroszlan,S.<br>Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity<br>Virology (1985) 145, 280-292. PubMed  Europe PubMed
  41. Toh,H., Kikuno,R., Hayashida,H., Miyata,T., Kugimiya,W., Inouye,S., Yuki,S. and Saigo,K.<br>Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of moloney murine leukaemia virus<br>EMBO J (1985) 4, 1267-1272. PubMed  Europe PubMed  PMC  EPMC
  42. Yoshinaka,Y., Katoh,I., Copeland,T.D. and Oroszlan,S.<br>Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon<br>Proc Natl Acad Sci U S A (1985) 82, 1618-1622. PubMed  Europe PubMed  PMC  EPMC
  43. 1977
  44. Yoshinaka,Y. and Luftig,R.B.<br>Properties of a P70 proteolytic factor of murine leukemia viruses<br>Cell (1977) 12, 709-719. PubMed  Europe PubMed